Company intelligence / Profile preview
Polifarma
Rome, Lazio, Italypolifarma.it ↗
- Ownership
- Private
- Employees
- ~160
- Development stage
- Commercial
01
Overview
Polifarma operates as a commercial-stage pharmaceutical company with a broad portfolio of hospital and prescription products across several therapeutic areas including CNS, cardiovascular, gastroenterology, ophthalmology and infectious disease. The Turkish entity is a leading producer of parenteral solutions and injectables for hospitals with significant manufacturing capacity.[1][2][3][4]
- Therapeutic areas
- GastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small moleculesParenteral solutions (IV infusions, injectables)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Italy – Ophthalmic area partnership with historical market company[1]Turkey – No major partnerships disclosed
Beyond the preview
Go deeper on Polifarma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Polifarma.